Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
548 trials across Europe, recruiting first
Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
BulgariaStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
AustriaStudy on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction
FranceStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
BulgariaA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
CzechiaA Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
FranceEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
BulgariaA study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanySafety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression
ItalyEfficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms
BulgariaEffect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial
SwedenPhase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease
GermanyThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
